GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,031 Cr | ₹915 Cr | ₹997 Cr | ₹364 Cr | ₹791 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,031 Cr |
| Mar2025 | ₹915 Cr |
| Mar2024 | ₹997 Cr |
| Mar2023 | ₹364 Cr |
| Mar2022 | ₹791 Cr |
How is Cash Flow from Operating Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,031 Cr | 12.75 | |
| Mar2025 | ₹915 Cr | -8.23 | |
| Mar2024 | ₹997 Cr | 173.87 | |
| Mar2023 | ₹364 Cr | -53.97 | |
| Mar2022 | ₹791 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹47,171.9 Cr | -1.2% | 16.2% | 50.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.2% |
16.2% |
50.2% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses